Protective Molecule Sidelined in Models of Amyotrophic Lateral Sclerosis

The study took place at the Virginia Tech Carilion Research Institute. The discovery in mice has implications for patients with ALS, also known as Lou Gehrig's disease. ‘Amyotrophic lateral sclerosis (ALS) strikes approximately 6,000 people in the U.S ...
News Type: